Glioblastoma accounts for about half of malignant brain tumors

Glioblastoma accounts for about half of malignant brain tumors
Image: Intellect (generated)

In short: A review of research on primary brain tumors in adults found that glioblastoma is the most common type, accounting for about 49% of cases. Malignant primary brain tumors affect roughly 7 per 100,000 people annually in the United States and cause more than 15,000 deaths a year, with overall five-year survival around 36%.

The review also reports that adding the chemotherapy drug temozolomide to radiotherapy improved outcomes for glioblastoma patients: two-year survival rose from 10.9% with radiotherapy alone to 27.2% with the combination, and five-year survival rose from 1.9% to 9.8%.

This is a review summarizing published studies and trial data rather than a new experiment, so the epidemiological figures reflect observed patterns and the treatment results come from earlier controlled trials it cites, not from new testing here.

Why it matters: Glioblastoma is the most common and deadliest type of primary brain cancer, and adding chemotherapy to radiation modestly improves survival.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/science-research-glioblastomas-represent-nearly-half-of-all-primary-malignant.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…